Zydus Lifesciences

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue2,1492,8313,0382,6942,478
Expenses1,7652,0122,0261,7261,904
EBITDA594.901,0241,2231,184805.90
EBIT473.30700.001,1021,059678.20
Profit Before Tax384.80615.001,013968.10574.30
Net Profit255.90490.70780.90805.00450.40
Financial Ratios
Operating Profit Margin30.81%33.64%42.63%57.75%36.22%
Net Profit Margin13.25%26.73%27.21%39.27%20.24%
Earning Per Share (Diluted)2.534.857.717.964.45
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ